Posted in | News

ThyssenKrupp Industrial Solutions Receives Order to Build Cement Clinker Production Line in Algeria

ThyssenKrupp Industrial Solutions, the ThyssenKrupp Group’s plant engineering specialist, has received an order to build a cement clinker production line in Algeria. The customer is Société des Ciments de Ain El Kebira (SCAEK), a subsidiary of Algerian cement manufacturer Groupe Industriel des Ciments d’Algérie (GICA).

The value of the contract is in the mid three-digit million euro range. The new 6,000 tons per day cement clinker plant will be built in Ain El Kebira, around 300 kilometers east of Algiers near the provincial capital Setif. Start-up is planned for 2016.

Dr. Hans Christoph Atzpodien, CEO of ThyssenKrupp Industrial Solutions: “The order validates our strategy of combining technological expertise with a strong presence in the world’s growth regions. We profit from infrastructure expansion in the emerging markets and, with our engineering expertise, help serve rising global demand for capital goods, energy and raw materials in a resource-friendly way.”

The order includes the supply of key components for operations including raw material processing, clinker manufacture and cement loading, the installation of a laboratory automation system for quality assurance and monitoring, and the turnkey handover of the plant to the customer.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.